Table 2 The 25 variable CpGs identified in converters as clinically relevant epimutations

From: Epigenetic variability in conversion to psychosis: novel findings from an innovative longitudinal methylomic analysis

CpG

p-value of F-test (FDR)

Genes

cg18796523

8.46E−04

ALG11; ATP7B

cg04087237

4.41E−02

CACNB4

chr16:50203861

9.91E−03

—

cg13303475

1.10E−02

NT5DC3

cg01918706

4.37E−02

UBE2T

cg01657694

3.09E−02

KLHL22

cg13694867

2.54E−02

SIM2

cg05168033

1.24E−03

EFEMP1

cg26952925

1.16E−02

ADCY9

cg13562542

5.93E−03

GPR27; EIF4E3

cg17364044

3.10E−02

PELI1

cg26447413

2.02E−02

GAS1

cg11265160

1.48E−02

TMEM132C

cg21849932

1.87E−02

LIME1

cg04364540

4.27E−03

FAM160B1

cg14099514

1.02E−02

PLCXD3

cg19176559

3.46E−03

—

cg19041132

6.22E−07

SPHK1

cg12053442

2.85E−02

—

cg01558909

1.85E−05

HBM

cg14993491

4.54E−03

PCSK9

cg13408519

3.24E−06

—

cg12604181

1.04E−09

CTSH

cg18404925

1.50E−07

RAC1

cg13978347

1.08E−04

ASTN2

  1. Significance in F-test are corrected by FDR
Back to article page